Loading clinical trials...
Loading clinical trials...
This study will evaluate the safety and efficacy of dutogliptin in patients with type 2 diabetes mellitus (T2DM) who are receiving background therapy of glimepiride with or without metformin.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Forest Laboratories
Collaborators
NCT02088658 · Diabetes Mellitus, Type 2, Diabetes Mellitus, Adult-Onset, and more
NCT06717256 · Diabetes Mellitus Self Management Education, Diabetes Mellitus, Type II, and more
NCT05364476 · Diabetes Mellitus, Type II
NCT04830969 · Diabetes Mellitus, Type II, Periodontitis
NCT03596177 · Diabetes Mellitus, Type II, Obesity
Forest Investigative Site 064
Birmingham, Alabama
Forest Investigative Site 020
Birmingham, Alabama
Forest Investigative Site 025
Muscle Shoals, Alabama
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions